Small cell lung carcinoma (SCLC) is an extremely aggressive malignancy, characterized by a nearly universal genomic inactivation of RB1 and TP53, a high tumor mutational burden (TMB), and nearly invariable association with cigarette smoking (1). Here, TP53 is linked to neoplasm.